Join us anytime from Jan 26th - Feb 3rd for a virtual screening of The Human Trial! Register here ow.ly/hjMy50MByx6 and enter invitation code: THT-JDRF

WCHRI member Margie Davenport is involved in a collaboration that led to the creation of a UK version of CSEP’s Get Active Questionnaire for Pregnancy. The questionnaire is designed to inform individuals about getting active during pregnancy. Read: csep.ca/2023/01/23/cse…

Join us @ubc Vancouver from June 19-21 for the Islet Study Group Meeting 2023. #IsletStudyGroup #BetaCellWorkshop #IsletsInVan2023 Registration is now open! event.fourwaves.com/isg2023/pages

It’s been a while since I used Twitter for this, but our lab is looking to recruit a new #postdoc, if anyone is interested in studying either #cardiac or #skeletal_muscle #energy #metabolism in #obesity or #rare_genetic_diseases, please DM me and others please RT

#T1D is tough and impacts on #mentalhealth We are looking for folks to help us design supports to help young adults cope with #diabetesdistress Do you have an hour to give for a virtual interview? In particular we need more representation from males

Check out DonnaFVine research PCOS Together on page 33 of the report

📢Our Research School for #Diabetes presents the 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐒𝐮𝐦𝐦𝐞𝐫 𝐈𝐧𝐭𝐞𝐫𝐧𝐬𝐡𝐢𝐩 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 𝐢𝐧 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬! The program is designed for #Bachelor and first-year #Master students. 🩸Apply Now: t1p.de/t1r5a

For Leslie Ann Bent, who experienced a heart attack in 2019, research has improved her ability to manage her diabetes. Read her story now. ow.ly/iIsz50MFJMy #LetsEndDiabetes #HeartMonth

some very exciting news to share that Amurtab received a fellowship from CIHR and we look forward to sharing his current work on developing new pharmaceutical agents that decrease #ketone #oxidation to promote #glucose_lowering in the future!

“Women tend to delay presenting. They are likely to say, ‘I’ll fix the kids’ breakfast and then go to the hospital.’” – Dr. Padma Kaul’s research examines ways to improve diagnosis and treatment of heart disease to save more women. #HeartMonth #BeatHealthInequity

📣 ADI Member Dr. Padma Kaul's @padma_Kaul Canadian VIGOUR Centre UAlberta Med & Dent research is focused on heart disease and risk factors - such as diabetes - to improve outcomes for women. #HeartMonth #Diabetes Read more Heart & Stroke heartandstroke.ca/articles/using…

Get your section 1 credits this April! 🎓 DU23 is now #accredited by the CSEM / SCEM The Royal College for section 1 credits. Visit diabetesupdate.ca for more information and to register. #DiabetesUpdate23 #CME #diabetes #DiabetesAwareness

healthinsight.ca/heart-health/i…

On June 4, join the Alberta Diabetes Institute (Alberta Diabetes) to celebrate 25 years since the Edmonton Protocol transformed diabetes care for Type 1 diabetes patients. This public event will feature an expert panel on diabetes research and an open Q&A. Happening at the

Are you a diabetes researcher, clinician or trainee? On June 5, Alberta Diabetes, with support from Gairdner Foundation, will bring together diabetes researchers to showcase and discuss leading edge diabetes research and treatments. Join us for a full day of scientific

The Edmonton Protocol was a turning point in the treatment of Type 1 diabetes patients. Twenty-five years later, hundreds of people have received the groundbreaking islet transplant procedure. On June 4, the Alberta Diabetes Institute (Alberta Diabetes) invites you to celebrate

Excited to be part of this process. ⁦Alberta Diabetes⁩ Medical Affairs team hosts international islet cell therapy workshops breakthrought1d.org/news-and-updat…

New in Experimental Physiology by John R. Ussher Alberta Diabetes UAlberta Pharmacy: The multifaceted roles of ketones in physiology 👇 physoc.onlinelibrary.wiley.com/doi/10.1113/EP…

Join the diabetes research community on June 5 at the Alberta Diabetes and Gairdner Foundation Scientific Symposium as part of the 25th anniversary celebrations of the Edmonton Protocol. This exciting event will include sessions on beta cell replacement therapy, immune responses

Excited to enroll our first participant for testing an agent (tolimidone) we hope will promote beta cell regeneration, building on preclinical work from Dr Jean Buteau at Alberta Diabetes . Supported by Alberta Diabetes Foundation & Biodexa Pharmaceuticals PLC ualberta.ca/en/folio/2023/…